Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

874 ARTÍCULOS , VIENDO DEL 391 AL 405

New Multiomic Studies Shed Light on Cellular Diversity and Neuronal Susceptibility in Parkinson's Disease

Liang M, Chu L, Yue Z.

Mov Disord. 2025 Mar;40(3):431-437. doi: 10.1002/mds.30097. Epub 2025 Jan 15.

Plasma alpha-synuclein predicts cognitive impairment in Parkinson's disease: a systematic review and meta-analysis

Zhu Z, Cordato D, Chen R, Xu YH, Shulruf B, Chan DKY.

J Neurol. 2025 Jan 15;272(2):124. doi: 10.1007/s00415-024-12871-7.

Gamma knife versus linear accelerator thalamotomy for essential tremor and Parkinson's disease: A systematic review and meta-analysis

Chintapalli R, Chang S, Kaprealian T, Savjani R, Tenn S, Bari A.

J Clin Neurosci. 2025 Mar;133:111050. doi: 10.1016/j.jocn.2025.111050. Epub 2025 Jan 16.

Changes in sensor recorded activity patterns and neuropsychiatric symptoms after deep brain stimulation for Parkinson's disease: 5 case reports

Bruhin LC, Single M, Naef AC, Petermann K, Sousa M, Castelli M, Debove I, Maradan-Gachet ME, Magalhães AD, Diamantaras AA, Lachenmayer ML, Tinkhauser G, Waskönig J, El Achkar CM, Lemkaddem A, Lemay M, Krack P, Nef T, Amstutz D.

BMC Neurol. 2025 Jan 17;25(1):25. doi: 10.1186/s12883-025-04030-w.

Response to the letter "Reassessing the hypothesis of essential tremor as a prodromal feature of Parkinson's disease"

Yilmaz AY, Jankovic J.

Parkinsonism Relat Disord. 2025 Mar;132:107280. doi: 10.1016/j.parkreldis.2025.107280. Epub 2025 Jan 12.

Essential Tremor Suppression with a Novel Anti-Tremor Orthosis: A Randomized Crossover Trial

Mugge W, Elstgeest LEM, van Ginkel M, Pol L, de Lange I, Pambakian N, Assis de Souza A, Helmich RC, Kamphuis DJ.

Mov Disord. 2025 Mar;40(3):445-455. doi: 10.1002/mds.30082. Epub 2025 Jan 21.

Fast micrographia and frontal lobe dysfunction post-traumatic brain injury: insights into pacing impairment and rehabilitation strategy

Fukui J, Yamaga T, Anmoto N, Inagaki A.

BMJ Case Rep. 2025 Jan 21;18(1):e262065. doi: 10.1136/bcr-2024-262065.

Validation of the Portuguese version of the Movement Disorder Society non-motor rating scale (MDS-NMS) in Parkinson's disease

Vale TC, Santos DP, Oliveira DS, Paula Brandão PR, Pereira DA, Bouça-Machado R, Silva LO, Mello Rieder CR, Barbosa ER, Cury RG, Parmera JB, Ghizoni Teive HA, Ferreira MG, Ferraz HB, Candeias da Silva C, Tumas V, Nunes Cunha AL, Braga-Neto P, Lima DP, Della Colleta MV, Maia D, de Souza Fontana M, Damas CN, Lobo PP, Rebordão L, Magalhães AD, Peralta AR, Simões RM, Lampreia T, Velon AG, Carneiro D, Raimundo R, Gago M, Mendes A, Chã NV, Damásio J, Costa S, Lopes R, Morgadinho A, Mestre T, Stebbins GT, Luo S, Goetz CG, Ferreira JJ, Cardoso F; MDS-NMS Portuguese Validation Study Group.

Parkinsonism Relat Disord. 2025 Mar;132:107276. doi: 10.1016/j.parkreldis.2025.107276. Epub 2025 Jan 13.

Canadian Association of Radiologists Central Nervous System Diagnostic Imaging Referral Guideline

Hamel C, Avard B, Dea N, Margau R, Mattar A, Michaud A, Schmidt M, Volders D, Witiw C, Worrall J, Murphy A.

Can Assoc Radiol J. 2025 Aug;76(3):435-443. doi: 10.1177/08465371241311247. Epub 2025 Jan 30.

Re-examining the pathobiological basis of gait dysfunction in Parkinson's disease

Cho N, Kalia LV, Kalia SK.

Trends Neurosci. 2025 Mar;48(3):189-199. doi: 10.1016/j.tins.2025.01.002. Epub 2025 Jan 29.

Retrospective database analysis on the demographics and resource utilization of patients with Parkinson's disease in Quebec, Canada

Baribeau V, Mohammed S, Awan A, Parison D, Lachaine J.

Clin Park Relat Disord. 2025 Jan 12;12:100300. doi: 10.1016/j.prdoa.2025.100300. eCollection 2025.

The basics of PET molecular imaging in neurodegenerative disorders with dementia and/or parkinsonism

Bronte A, Prieto E, Quincoces G, Erro E, Arbizu J.

Eur Radiol. 2025 Aug;35(8):4621-4634. doi: 10.1007/s00330-025-11388-5. Epub 2025 Feb 6.

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial

Vijiaratnam N, Girges C, Auld G, McComish R, King A, Skene SS, Hibbert S, Wong A, Melander S, Gibson R, Matthews H, Dickson J, Carroll C, Patrick A, Inches J, Silverdale M, Blackledge B, Whiston J, Hu M, Welch J, Duncan G, Power K, Gallen S, Kerr J, Chaudhuri KR, Batzu L, Rota S, Jabbari E, Morris H, Limousin P, Greig N, Li Y, Libri V, Gandhi S, Athauda D, Chowdhury K, Foltynie T.

Lancet. 2025 Feb 22;405(10479):627-636. doi: 10.1016/S0140-6736(24)02808-3. Epub 2025 Feb 4.

Classification and Genotype-Phenotype Relationships of GBA1 Variants: MDSGene Systematic Review

Rossi M, Schaake S, Usnich T, Boehm J, Steffen N, Schell N, Krüger C, Gül-Demirkale T, Bahr N, Kleinz T, Madoev H, Laabs BH, Gan-Or Z, Alcalay RN, Lohmann K, Klein C.

Mov Disord. 2025 Apr;40(4):605-618. doi: 10.1002/mds.30141. Epub 2025 Feb 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias